Oncology Portfolio
Precision Markers.
Precision Markers.
Rapid Results.
Genes2Me’s oncology point-of-care assay portfolio supports rapid molecular detection of key cancer-associated genetic markers used in diagnosis, prognosis, and therapy monitoring. The range includes assays for clinically significant targets such as BCR-ABL, JAK2, FLT3, PML-RARA, and HLA-B27.
50+Assays
RT-PCRTechnology
IVDCertified
Hereditary & Hematological Kits
BCR-ABL Real-Time PCR Kit
BCR-ABL Quantitative Real Time PCR Kit
HLA B27-Q Real Time PCR Kit
PML-RARA Real Time PCR Kit
JAK-2-Q Real Time PCR Kit
FLT3-Q Real-Time PCR Kit
Compatible Specimens
Whole Blood
Saliva
Nasopharyngeal Swabs
Plasma / Serum
Urine
Fresh Tissue